Ontology highlight
ABSTRACT:
SUBMITTER: Rubenstein JL
PROVIDER: S-EPMC3563362 | biostudies-literature | 2013 Jan
REPOSITORIES: biostudies-literature
Rubenstein James L JL Li Jing J Chen Lingjing L Advani Ranjana R Drappatz Jan J Gerstner Elizabeth E Batchelor Tracy T Krouwer Hendrikus H Hwang James J Auerback Glenna G Kadoch Cigall C Lowell Clifford C Munster Pamela P Cha Soonmee S Shuman Marc A MA Damon Lloyd E LE
Blood 20121129 5
<h4>Unlabelled</h4>Recurrent CNS lymphoma continues to be associated with poor outcomes in the rituximab era. Although IV rituximab mediates superior disease control of systemic non-Hodgkin lymphoma (NHL), it fails to completely eliminate the risk of meningeal recurrence, likely due to minimal CNS penetration. Given that rituximab acts synergistically with chemotherapy, we conducted the first phase 1 study of intraventricular immunochemotherapy in patients with recurrent CNS NHL. Fourteen patien ...[more]